Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for ADDLF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ADDLF and 80,000+ other tickers.
See exactly how ADDLF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ADDLF and 80,000+ other tickers.
AddLife AB (publ) is a prominent supplier of specialized equipment, medical devices, and reagents. The company primarily caters to healthcare systems, research organizations, and academic institutions, while also serving the food and pharmaceutical industries. Its operations are structured into two distinct segments: Labtech and Medtech. The Labtech segment delivers products, complete solutions, and services crucial for diagnostics, biomedical research, and laboratory work. This includes offerings across a broad spectrum such as haematology, pathology, point-of-care diagnostics, cell biology…
AddLife AB (publ) (ADDLF) Q2 2026 Earnings Call Transcript
AddLife AB (publ) (ADDLF) Q1 2026 Earnings Call Transcript
AddLife AB (publ) (ADDLF) Q4 2025 Earnings Call Transcript